Bryan Smith, associate professor of biomedical engineering at MSU, and a team of scientists created a “Trojan Horse” nanoparticle that can be directed to eat debris, reducing and stabilizing plaque. The discovery could be a potential treatment for atherosclerosis, a leading cause of death in the United States.
The results, published in the current issue of Nature Nanotechnology, showcases the nanoparticle that homes in on atherosclerotic plaque due to its high selectivity to a particular immune cell type – monocytes and macrophages. Once inside the macrophages in those plaques, it delivers a drug agent that stimulates the cell to engulf and eat cellular debris. Basically, it removes the diseased/dead cells in the plaque core. By reinvigorating the macrophages, plaque size is reduced and stabilized.
Smith said that future clinical trials on the nanoparticle are expected to reduce the risk of most types of heart attacks, with minimal side effects due to the unprecedented selectivity of the nanodrug.
Smith’s studies focus on intercepting the signaling of the receptors in the macrophages and sending a message via small molecules using nano-immunotherapeutic platforms. Previous studies have acted on the surface of the cells, but this new approach works intracellularly and has been effective in stimulating macrophages.
“We found we could stimulate the macrophages to selectively eat dead and dying cells – these inflammatory cells are precursor cells to atherosclerosis – that are part of the cause of heart attacks,” Smith said. “We could deliver a small molecule inside the macrophages to tell them to begin eating again.”
This approach also has applications beyond atherosclerosis, he added.
“We were able to marry a groundbreaking finding in atherosclerosis by our collaborators with the state-of-the-art selectivity and delivery capabilities of our advanced nanomaterial platform. We demonstrated the nanomaterials were able to selectively seek out and deliver a message to the very cells needed,” Smith said. “It gives a particular energy to our future work, which will include clinical translation of these nanomaterials using large animal models and human tissue tests. We believe it is better than previous methods.”
Smith has filed a provisional patent and will begin marketing it later this year.
A link to the original paper: https://www.nature.com/articles/s41565-019-0619-3
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Trojan Horse nanoparticle
- "Trojan Horse" Nanoparticles Kill Cancer Cells Without Drugson October 6, 2020 at 10:16 am
Scientists have created a “Trojan horse” that sneaks anticancer nanoparticles into cancer cells and causes them to self-destruct without any drugs. The res ...
- Cancer Cells Destroyed in Experimental Treatment without Using Any Drugson September 28, 2020 at 6:41 am
TEHRAN (Tasnim) – One of the latest methods pioneered by scientists to treat cancer uses a Trojan horse sneak attack to prompt cancer cells to self-destruct – all without using any drugs. Key to the ...
- ‘Trojan horse’ treatment makes cancer self-destruct without use of drugson September 28, 2020 at 3:40 am
A new experimental treatment reportedly tricks cancer cells into self-destructing, without the use of any drugs, providing new hope for winning the war on many different types of the disease.
- Experimental Cancer Treatment Destroys Cancer Cells Without Using Any Drugson September 24, 2020 at 7:46 am
One of the latest methods pioneered by scientists to treat cancer uses a Trojan horse sneak attack to prompt cancer cells to self-destruct – all without using any drugs. Key to the technique is the ...
- Trojan horse nanoparticle takes a drug-free approach to killing canceron September 23, 2020 at 7:48 pm
With cancer so often presenting as a cunning enemy, scientists are working hard to develop therapies that can slip through its array of crafty defenses. These types of “Trojan horse” approaches use ...
Go deeper with Google Headlines on:
Trojan Horse nanoparticle
Go deeper with Bing News on:
- Latest Research Evaluating VASCEPA® (Icosapent Ethyl) Mechanisms of Action Presented at European Atherosclerosis Society (EAS) Congress 2020on October 5, 2020 at 5:00 am
Amarin Corporation plc today announced the presentation of new data at European Atherosclerosis Society Congress 2020, being held virtually from October 4– October 7, 2020 that add to the growing body ...
- How hormone therapy slows progression of atherosclerosison October 1, 2020 at 6:22 am
Atherosclerosis is a chronic inflammatory process of blood vessels that is central to most cases of cardiovascular disease. (Unsplash) As one of the most common treatments for effectively managing ...
- Lipid metabolism controls lung cancer metastasis, not just diseases like atherosclerosison September 30, 2020 at 7:10 am
Most cancer deaths ultimately occur as a result of metastasis. Previous reports have demonstrated that fat tissue can provide energy support to the disseminated tumor cells that increases the survival ...
- Hormone Therapy Can Slow Down The Progression of Atherosclerosis in Menopausal Womenon September 29, 2020 at 9:01 pm
One of them is slowing the progression of atherosclerosis, a chronic inflammatory condition that causes cardiovascular diseases. Hormone therapy is a very common treatment to manage menopause ...
- Mechanism of Action of Hormone Therapy In Atherosclerosis Revealedon September 28, 2020 at 4:45 am
Mechanism of benefits offered by hormonal therapy against atherosclerosis was evaluated in a study named Early Versus Late Intervention Trial With Estradiol (ELITE). Atherosclerosis is a chronic ...